pith. sign in

USPTO: us-12635627 · published 2026-05-26 · patents · A01H 1/126· A01H 1/045· A01H 1/06· A01H 6/825· C12Q 1/6895· C12Q 2600/13

Plants resistant to infection by pepino mosaic virus

Pith reviewed 2026-05-28 01:30 UTC · model grok-4.3

classification patents A01H 1/126A01H 1/045A01H 1/06A01H 6/825C12Q 1/6895C12Q 2600/13
keywords pepino mosaic virusplant virus resistancegenetic resistanceamino acid sequencetomatoplant breedingtransgenic plant
0
0 comments X

The pith

A plant carrying a gene for the protein of SEQ ID NO: 2 or SEQ ID NO: 3 resists infection by pepino mosaic virus.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The patent describes a plant or plant part that carries a gene encoding a protein whose amino acid sequence matches SEQ ID NO: 2, SEQ ID NO: 3, or both. This genetic feature is presented as the basis for observable resistance to pepino mosaic virus and for an improved resistance phenotype. The claim applies to whole plants, reproductive material, propagating material, and individual plant cells. If the stated sequence is sufficient to produce resistance, breeders could introduce the gene into susceptible varieties without further sequence changes. The patent frames the sequence itself as the distinguishing and protective element.

Core claim

The central claim is that the presence of a gene encoding a protein comprising the amino acid sequence of SEQ ID NO: 2 and/or SEQ ID NO: 3 is what produces resistance to PepMV infection or an improved resistance phenotype in the plant or plant material.

What carries the argument

A gene encoding the protein defined by amino acid sequence SEQ ID NO: 2 and/or SEQ ID NO: 3; the sequence is asserted to be the element that confers the resistance phenotype.

If this is right

  • Growers could deploy the sequence in commercial tomato or other host crops to reduce yield loss from PepMV.
  • Seed companies could breed or transform varieties by inserting or selecting for the gene without additional modifications.
  • Resistance would be heritable through reproductive or propagating material that retains the gene.
  • The same sequence could be tested for use in multiple plant species that are natural hosts of PepMV.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • If the sequence alone is causal, targeted gene editing could introduce resistance into elite lines that currently lack it.
  • Field performance data would be needed to confirm that resistance holds under varying infection pressures and climates.
  • The approach could be extended to related viruses if the protein interferes with a conserved viral process.

Load-bearing premise

The amino acid sequence is what actually causes the resistance rather than some other linked genetic or environmental factor.

What would settle it

A controlled test in which plants carrying only the stated gene and sequence show no measurable reduction in PepMV infection rate or symptom severity compared with near-isogenic plants lacking the sequence.

read the original abstract

1 . A plant or part thereof, reproductive or propagating plant material or a plant cell showing resistance to infection by pepino mosaic virus (PepMV) or improved phenotype in terms of PepMV infection resistance, characterized in that it comprises a gene which encodes for a protein, wherein said protein comprises an amino acid sequence of SEQ ID NO: 2 and/or SEQ ID NO: 3.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

1 major / 0 minor

Summary. The manuscript (a patent document) asserts that a plant or plant part comprising a gene encoding a protein with amino acid sequence SEQ ID NO: 2 and/or SEQ ID NO: 3 exhibits resistance to Pepino mosaic virus (PepMV) infection. The sole substantive content is this bare claim (abstract/claim 1); no methods, constructs, infection assays, controls, or phenotypic data are supplied.

Significance. If experimentally validated, a sequence-specific resistance trait would be of clear practical interest for tomato and related crop protection. The supplied text, however, contains no data, derivations, or validation steps that would allow assessment of whether the claimed causal link holds.

major comments (1)
  1. [Abstract/claim 1] Abstract/claim 1: the central assertion that a gene encoding SEQ ID NO: 2 and/or SEQ ID NO: 3 produces PepMV resistance is stated without any supporting infection assays, transgenic construction details, controls, or phenotypic measurements. This renders the claim an unsupported assertion rather than a substantiated result.

Simulated Author's Rebuttal

1 responses · 1 unresolved

We thank the referee for the review. The submitted document is a patent claim (US12635627), not a research article; its purpose is to define the legal scope of the asserted invention rather than to present experimental results.

read point-by-point responses
  1. Referee: [Abstract/claim 1] Abstract/claim 1: the central assertion that a gene encoding SEQ ID NO: 2 and/or SEQ ID NO: 3 produces PepMV resistance is stated without any supporting infection assays, transgenic construction details, controls, or phenotypic measurements. This renders the claim an unsupported assertion rather than a substantiated result.

    Authors: Patent claims are written as concise legal statements that define the protected subject matter; they are not required to embed methods, data, or controls. Enablement and support for the claim are supplied in the full patent specification and examples, which are separate from the claim text itself. The present excerpt contains only the claim language. revision: no

standing simulated objections not resolved
  • No experimental infection assays, transgenic methods, or phenotypic data are present in the document to substantiate the resistance phenotype.

Circularity Check

0 steps flagged

No derivation chain exists; bare patent claim with no equations or predictions

full rationale

The supplied patent text consists solely of a claim asserting that a gene encoding SEQ ID NO:2 and/or SEQ ID NO:3 confers PepMV resistance. No derivation, model, fitted parameters, predictions, or self-citations are present. None of the enumerated circularity patterns apply because there is no chain of reasoning that could reduce to its own inputs. The document is therefore self-contained against external benchmarks by virtue of containing no internal derivation at all.

Axiom & Free-Parameter Ledger

0 free parameters · 0 axioms · 0 invented entities

The claim rests on the untested premise that the listed sequence produces resistance; no free parameters, axioms, or invented entities are articulated beyond the sequence itself.

pith-pipeline@v0.9.0 · 5673 in / 882 out tokens · 22194 ms · 2026-05-28T01:30:30.905662+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.